Researchers using intranasal retatrutide should monitor the same parameters as those using the injectable form: body weight, appetite changes, gastrointestinal symptoms, blood pressure, and heart rate
Future research priorities encompass mechanistic investigations to enable next-generation therapeutic development, clinical trials exploring novel indications and combination approaches, technological innovations improving drug delivery and patient monitoring, and implementation research addressing real-world effectiveness and healthcare system integration
Description: Calcitonin Acetate Salmon CT, KC, CGRP, CALC1, CGRP1, CGRP-I, MGC126648, katacalcin, Calcitonin gene-related peptide 1 precursor, Calcitonin gene-related peptide I
Injections may be prescribed to treat symptoms and depression associated with premenstrual syndrome (PMS)